The Danish Embassy in Beijing hosted a medical pricing and reimbursement seminar on 15 October with the aim to build bridges between the Danish and the Chinese ways of pricing medicine.
The seminar was a means for Danish stakeholders to share their knowledge about the Danish health care system and way of pricing medicine with Chinese officials, and the Chinese division of the pharmaceutical company, Ferring.
R&D is China’s future
Ferring’s General Manager in China, Fei Jia, as well Deputy Director from the Ministry of Human Resources and Social Security, Huang Xinyu, participated in the event.
Also participating were China Health Insurance Research Association (CHIRA) Director General Xiong Xianjun, as well as officials from the Chinese Ministry of Health and other officials from a row of health organisations.
Danish Embassy Commercial Counsellor Jens Moth opened the seminar.
“The Danish health system’s acknowledgement of the need of the industry’s constant research and development in order to improve treatment efficiencies is an example to follow for other countries when they build up new health systems,” said Moth at the opening.
“This is particularly relevant for a country such as China, where the debate currently tends to focus on short-term cost cuttings alone.”
Danish knowledge of Chinese health development
After Moth’s opening, Maria Friis Larsen from the Danish Ministry of Health held a speech about the Danish advantages when it comes to pricing, reimbursement and primary care.
“The development and incremental adjustments of the Danish system over the last 50 years have resulted in a solid system from which other countries can find valuable inspiration,” she said.
“With the challenges China currently is facing for building up a new health infrastructure, the mind set as well as the technical details behind the Danish system are obviously very interesting topics for our Chinese colleagues,” Larsen added.
The seminar is part of a larger project to set the ground for greater collaboration in the health pricing and reimbursement area.
The Danish Embassy has arranged events from 14 till 19 of October with pharmaceutical companies Novo Nordisk, Coloplast and Lundbeck in the Chinese cities of Zhengzhou, Urumqi and Jinan. Before being held in Beijing, a similar seminar was held in Hainan.